MedAssets completed a 17 year round trip voyage from Private Equity ownership, to a publicly-traded company rolling up acquisitions, and back to Private Equity ownership with its $2.8 billion sale, which represents a rich 3.6X revenues and 12.7X EBITDA.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.